DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Ruof J, Dintios CM, Schwartz F.
Early benefit assessment (EBA) in Germany: differences between pharmaceutical companies’ claims and IQWIG benefit assessments. Abstract PHP 148; ISPOR 15th Annual European Congress, 3–7 November 2012, Berlin, Germany.
Value Health 2012;
15 (07) A315
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.